Does EFAVIRENZ Cause Interstitial lung disease? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Interstitial lung disease have been filed in association with EFAVIRENZ (Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate). This represents 0.2% of all adverse event reports for EFAVIRENZ.
15
Reports of Interstitial lung disease with EFAVIRENZ
0.2%
of all EFAVIRENZ reports
0
Deaths
8
Hospitalizations
How Dangerous Is Interstitial lung disease From EFAVIRENZ?
Of the 15 reports, 8 (53.3%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EFAVIRENZ. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does EFAVIRENZ Cause?
Virologic failure (916)
Foetal exposure during pregnancy (701)
Drug resistance (654)
Drug interaction (645)
Viral mutation identified (641)
Depression (602)
Pathogen resistance (567)
Maternal exposure during pregnancy (478)
Treatment failure (390)
Immune reconstitution inflammatory syndrome (301)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which EFAVIRENZ Alternatives Have Lower Interstitial lung disease Risk?
EFAVIRENZ vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL
EFAVIRENZ vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL
EFAVIRENZ vs EFFEXOR
EFAVIRENZ vs EFFIENT
EFAVIRENZ vs EFGARTIGIMOD ALFA